View on market: Volatility Prevails, Market is searching for better value
Following the lead set by Wall Street’s overnight advances, the majority of markets in the Asia-Pacific area saw higher opening activity on Wednesday. At 6:30 a.m., the KOSPI index was up 31.35 points, or 1.22%, at 2,607.55 and the S&P ASX 200 was up 42.80 points, or 0.56%, at 7,624.40. Japan’s markets were trading negatively, defying the overall trend. As of 06:31 a.m., the Nikkei 225 was down 67.64 points, or 0.19%, at 36,093.02. Following a two-day meltdown, the U.S. bond market recovered as investors looked to a number of Federal Reserve speakers for indications about how the most recent economic data would affect their rate forecast, according to Bloomberg. On Tuesday, the Nasdaq 100 and the S&P 500 index both saw increases of 0.23%. The Dow Jones Industrial Average rose by 0.37%.
Economic Calendar:
- USD : Initial Jobless Claims on 08th February, 2024
- USD : CPI (MoM) (Jan) on 13th February, 2024
- INR : M3 Money Supply on 07th February, 2024
- INR : Interest Rate Decision on 08th February, 2024
Brokerage Radar:
MS ON BHARTI AIRTEL: EW, TP Rs 1015; Steady performance; Key highlights:
- a) Beat in India mobile business revenues and EBITDA led by improving subscriber mix;
- b) flattish capex qoq coming lower than our estimate;
- c) robust cash flow generation.
GS ON ASHOK LEYLAND: Buy, TP Rs 230; 3Q beat as a combination of pricing discipline, favorable RM prices & ongoing optimization in cost Gross margin of 27.8% was 150bps higher than BBG cons; EBITDA margin of 12.%, highest 3Q margin in co’s history (+320bps yoy)
CLSA ON REC: Buy, TP Rs 510; 3Q net profit of Rs33bn up 14% YoY driven by healthy growth in net interest income; Loan growth of 21% YoY strong; Expected negative credit cost in 3Q, but recoveries in one of resolved projects lower
36bp QoQ decline in GNPA is healthy
International Markets:
U.S & Europe:
Particulars | 06th February | Chg. | Chg.(%) |
Nasdaq | 15609.00 | 11.32 | 0.07 |
Dow | 38521.36 | 141.24 | 0.37 |
FTSE | 7681.01 | 68.15 | 0.89 |
CAC | 7638.97 | 49.01 | 0.64 |
DAX | 17033.24 | 129.18 | 0.76 |
Dow Fut.* | 38565.62 | 46.25 | 0.12 |
Asian markets:
Particulars | 07th February | Chg. | Chg.(%) |
GIFT Nifty | 22112.50 | 108.00 | 0.49 |
Nikkei | 36122.57 | -38.09 | -0.11 |
Straits Times | 3160.29 | 34.61 | 1.11 |
Hang Seng | 16236.71 | 99.84 | 0.62 |
Shanghai | 2813.70 | 24.21 | 0.87 |
ADR Watch:
Particulars | 06th February | Chg. | Chg.(%) |
Dr. Reddy | 73.25 | 0.40 | 0.54 |
HDFC Bank | 56.04 | 0.57 | 1.03 |
ICICI Bank | 24.66 | 0.12 | 0.49 |
Infosys | 20.60 | 0.30 | 1.48 |
Wipro | 5.95 | 0.18 | 3.03 |
Commodities & Currency:
Particulars | Current Price | Chg.(%) |
USD/INR | 83.05 | -0.02 |
Brent | 78.71 | 0.15 |
Gold | 2050.80 | -0.03 |
Silver | 22.46 | -0.09 |
FIIs & DIIs:
Particulars | 06th February | 05th February |
FIIs | 92.52 | 518.88 |
DIIs | 1096.26 | -1188.68 |
News Update:
UPL: Moody’s Investors Service downgraded the company’s senior unsecured rating to ‘Ba1’ from ‘Baa3’ on deterioration in the agrochemical industry fundamentals.
JB Chemicals & Pharmaceuticals: The company appointed Narayan Saraf as chief financial officer effective Feb. 23.
Biocon: The company received USFDA tentative approval for Dasatinib tablets, which are used in the treatment of the Philadelphia chromosome.
Lupin: The company received USFDA approval from ANDA for bromfenac ophthalmic solution, which is a generic of bromsite.
Power Finance Corp: The company incorporated Bhadla-III and Bikaner-III transmission as a wholly owned subsidiary for the development of transmission system strengthening for interconnections of the Bhadla III and Bikaner-II complexes.
Yasho Industries: The company begins a trial run at the Bharuch unit for manufacturing industrial chemicals.
Karnataka Bank: The company received an RBI nod for exercising the call option on bonds.
Mahindra Lifespace Developers: The company received an Irdai nod for a Rs 1,612 crore capital infusion by Axis Bank, subject to CCI approval.
Mahindra Life: The company received a Rs 2.3 crore penalty for non-adherence to forest norms.
One 97 Communications: Paytm’s Founder Vijay Shekhar Sharma has met Finance Minister Nirmala Sitharaman, reports CNBC-TV18, quoting sources. Sharma is likely to have to discuss the current situation with respect to Paytm.
FSN E-Commerce Ventures: The Nykaa brand operator has recorded a 106 percent on-year growth in net profit at Rs 17.5 crore for the quarter ended December FY24, with revenue increasing 22 percent to Rs 1,788.8 crore and gross merchandise value growing 29 percent over a year-ago period. EBITDA for the quarter jumped 26 percent YoY to Rs 98.8 crore, with a margin expansion of 20 bps at 5.5 percent in Q3 FY24.
Source: Moneycontrol, Bloomberg Quint, Investing
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Kiran Tahlani, Elite Wealth Limited, kirantahlani@elitestock.com
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
- Reports
- a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
- Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL has never been engaged in market making activity for the subject company;
(6) EWL shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.